Shantell Laketa Heiber

Array ( [id] => 1531155 [patent_doc_number] => 06410030 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process' [patent_app_type] => B1 [patent_app_number] => 09/654289 [patent_app_country] => US [patent_app_date] => 2000-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18410 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410030.pdf [firstpage_image] =>[orig_patent_app_number] => 09654289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531726 [patent_doc_number] => 06410222 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'In ovo vaccination of marek\'s disease type I virus' [patent_app_type] => B1 [patent_app_number] => 09/622093 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4316 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410222.pdf [firstpage_image] =>[orig_patent_app_number] => 09622093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558515 [patent_doc_number] => 06436408 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Cold -adapted equine influenza viruses' [patent_app_type] => B1 [patent_app_number] => 09/634159 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15423 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436408.pdf [firstpage_image] =>[orig_patent_app_number] => 09634159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017646 [patent_doc_number] => 06890538 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Immunization against herpes simplex virus' [patent_app_type] => utility [patent_app_number] => 10/048623 [patent_app_country] => US [patent_app_date] => 2000-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 10359 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890538.pdf [firstpage_image] =>[orig_patent_app_number] => 10048623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484664 [patent_doc_number] => 06365343 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Intercellular adhesion molecule powder formulation' [patent_app_type] => B1 [patent_app_number] => 09/117087 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3556 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365343.pdf [firstpage_image] =>[orig_patent_app_number] => 09117087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585191 [patent_doc_number] => 06358744 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Stabilized human papillomavirus formulations' [patent_app_type] => B1 [patent_app_number] => 09/624482 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12835 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358744.pdf [firstpage_image] =>[orig_patent_app_number] => 09624482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439907 [patent_doc_number] => 06495361 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Method of producing infectious papillomavirus in placental cells' [patent_app_type] => B1 [patent_app_number] => 09/621579 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6907 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495361.pdf [firstpage_image] =>[orig_patent_app_number] => 09621579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958716 [patent_doc_number] => 06953661 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-11 [patent_title] => 'Method of preventing transport of a neurotropic virus and identifying agents for achieving same' [patent_app_type] => utility [patent_app_number] => 10/031492 [patent_app_country] => US [patent_app_date] => 2000-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 17 [patent_no_of_words] => 5052 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953661.pdf [firstpage_image] =>[orig_patent_app_number] => 10031492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261090 [patent_doc_number] => 06664050 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Viral obesity methods and compositions' [patent_app_type] => B1 [patent_app_number] => 09/619117 [patent_app_country] => US [patent_app_date] => 2000-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5459 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664050.pdf [firstpage_image] =>[orig_patent_app_number] => 09619117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316395 [patent_doc_number] => 06605281 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Human papillomavirus vectors for the episomal transduction of host cells and method of making same' [patent_app_type] => B1 [patent_app_number] => 09/530047 [patent_app_country] => US [patent_app_date] => 2000-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13734 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605281.pdf [firstpage_image] =>[orig_patent_app_number] => 09530047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565280 [patent_doc_number] => 06376217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Fusion proteins and polynucleotides encoding gelonin sequences' [patent_app_type] => B1 [patent_app_number] => 09/610838 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 56569 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376217.pdf [firstpage_image] =>[orig_patent_app_number] => 09610838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392170 [patent_doc_number] => 06537556 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process' [patent_app_type] => B1 [patent_app_number] => 09/582876 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18413 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537556.pdf [firstpage_image] =>[orig_patent_app_number] => 09582876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573747 [patent_doc_number] => 06468504 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Composition comprising methylphenidate and another drug' [patent_app_type] => B1 [patent_app_number] => 09/597384 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2036 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468504.pdf [firstpage_image] =>[orig_patent_app_number] => 09597384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1569645 [patent_doc_number] => 06497883 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Porcine circovirus recombinant poxvirus vaccine' [patent_app_type] => B1 [patent_app_number] => 09/583545 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14729 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/497/06497883.pdf [firstpage_image] =>[orig_patent_app_number] => 09583545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073421 [patent_doc_number] => 06838084 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 09/980177 [patent_app_country] => US [patent_app_date] => 2000-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11173 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838084.pdf [firstpage_image] =>[orig_patent_app_number] => 09980177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999359 [patent_doc_number] => 06911207 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-28 [patent_title] => 'Cytotoxic T-cell epitopes of the papillomavirus L1-protein and use thereof in diagnostics and therapy' [patent_app_type] => utility [patent_app_number] => 09/980064 [patent_app_country] => US [patent_app_date] => 2000-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8084 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911207.pdf [firstpage_image] =>[orig_patent_app_number] => 09980064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533775 [patent_doc_number] => 06488935 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them' [patent_app_type] => B1 [patent_app_number] => 09/485973 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6423 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/488/06488935.pdf [firstpage_image] =>[orig_patent_app_number] => 09485973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311538 [patent_doc_number] => 06242250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions' [patent_app_type] => 1 [patent_app_number] => 9/577493 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4850 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242250.pdf [firstpage_image] =>[orig_patent_app_number] => 577493 [rel_patent_id] =>[rel_patent_doc_number] =>)